Safety, Tolerability, Pharmacokinetics and Antiviral Activity of GS-9669 in Subjects With Chronic Hepatitis C Virus Infection

Status:
Completed

Trial end date:
2012-05-01

Target enrollment:

Participant gender:

This is a research study to evaluate the safety, tolerability and anti-viral activity of GS-9669 in patients with Hepatitis C infection.

Phase 1

Gilead Sciences

Antiviral Agents